Celiac HLA DQ Association
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms | HLADQ |
| Cerner Primary Mnemonic | Celiac HLA DQ Association |
| EPIC Display Name | Celiac HLA DQ Association |
| Allscripts (AEHR) Order Name | Celiac HLA DQ Association |
| Sunrise Clinical Manager (SCM) Order Name | Celiac HLA DQ Association |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
HLADQ8 HLADQCOMM HLADQADDINFO HLADQ2 |
| Clinical Info |
Aids in the diagnosis of celiac disease. The HLA DQ Association test provides genotyping for detection of HLA-DQ2 (DQA1*05:01 or 05:05 and DQB1*02:01 or 02:02) and HLA-DQ8 (DQB1*03:02). Patients with DQ2, half DQ2 and/or DQ8 are predisposed to celiac disease. A negative result essentially rules out celiac disease. In addition to DQ2 and DQ8 status, the report also includes complete DQA and DQB genotypes, homozygosity for DQB1*02, and genetic risk assessment. |
| Specimen Type | |
| Container |
Lavender Top Tube |
| Collection Instructions |
Container/Tube: Lavender EDTA tube Specimen: 7 mL whole Blood (3mL min) Transport Temperature: Room Temperature Protect from extreme heat or cold. Limitations The HLA DQ Association test detects celiac disease-associated alleles that predispose to the disorder but is not diagnostic of celiac disease. More than 95% of celiac disease patients are positive for DQ2, half DQ2, or DQ8, but many individuals with these genetic results do not develop celiac disease. Even with appropriate precautions, an occasional specimen may not be satisfactory for testing. In such cases, fresh specimens should be collected for retesting. |
| Transport Instructions |
Room Temperature Protect from extreme heat or cold. |
| Specimen Stability | |
| Methodology |
Polymerase chain reaction (PCR)/sequence-specific oligonucleotide probes (Luminex®) This is a class II antigen level and an allele level test. |
| Days Performed |
TAT 4- 8 Days |
| Performing Laboratory |
LabCorp of America |
| CPT |
81377 x 2 |
| PDM |
1559863 |
Desired Epic Build Celiac HLA DQ Association
| Cerner Primary Mnemonic: | Celiac HLA DQ Association | |||||||||||||||
| PDM | 1559863 | |||||||||||||||
| Informatics - Workgroup | Immunology | |||||||||||||||
| Synonyms * | HLADQ | |||||||||||||||
| Display Name * | Celiac HLA DQ Association | |||||||||||||||
| Order Entry Specimen Sources * | ||||||||||||||||
| Order Entry Specimen Types |
Blood
| |||||||||||||||
| Specimen Navigator Specimen Types | ||||||||||||||||
| Specimen Navigator Specimen Sources | ||||||||||||||||
| Specimen Navigator Short Name | ||||||||||||||||
| Ordering info (EPIC SmartText) | Aids in the diagnosis of celiac disease. The HLA DQ Association test provides genotyping for detection of HLA-DQ2 (DQA1*05:01 or 05:05 and DQB1*02:01 or 02:02) and HLA-DQ8 (DQB1*03:02). Patients with DQ2, half DQ2 and/or DQ8 are predisposed to celiac disease. A negative result essentially rules out celiac disease. In addition to DQ2 and DQ8 status, the report also includes complete DQA and DQB genotypes, homozygosity for DQB1*02, and genetic risk assessment. | |||||||||||||||
| IP Orderable | Yes | |||||||||||||||
| OP Orderable | Yes | |||||||||||||||
|
AOEs * | ||||||||||||||||
| AP AOEs | ||||||||||||||||
| Special History | No | |||||||||||||||
| Build Comments | ||||||||||||||||
| Filter * | genetics | |||||||||||||||
| Procedure Category Change | ||||||||||||||||
Cerner Results
| ||||||||||||||||
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 114140 | ||||||||||||||||||||||||||||||
| Pdm | 1559863 | ||||||||||||||||||||||||||||||
| Order Display Name | Celiac HLA DQ Association | ||||||||||||||||||||||||||||||
| Procedure Name | CELIAC HLA DQ ASSOCIATION | ||||||||||||||||||||||||||||||
| Procedure Master Number | LAB10810 | ||||||||||||||||||||||||||||||
| Short Procedure Name | CELIAC HLA DQ ASSOCIATION | ||||||||||||||||||||||||||||||
| Category Code | 1.0 | ||||||||||||||||||||||||||||||
| Category Code Record Name | LAB BLOOD ORDERABLES | ||||||||||||||||||||||||||||||
| Synonyms | HLADQ | ||||||||||||||||||||||||||||||
| Clinically Active | Yes | ||||||||||||||||||||||||||||||
| Orderable | Yes | ||||||||||||||||||||||||||||||
| Performable | Yes | ||||||||||||||||||||||||||||||
| Filter Genomics | Generic Genomics Procedure | ||||||||||||||||||||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/114140 | ||||||||||||||||||||||||||||||
| Ordering Instructions | |||||||||||||||||||||||||||||||
| Default Specimen Type | Blood | ||||||||||||||||||||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||||||||||||||||||||
| Specimen Type List | |||||||||||||||||||||||||||||||
| Op Specimen Type List | |||||||||||||||||||||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||||||||||||||
| Specimen Source List | |||||||||||||||||||||||||||||||
| Op Specimen Source List | |||||||||||||||||||||||||||||||
| Ip Lab Test Components For Report | |||||||||||||||||||||||||||||||
| Op Lab Test Components For Report | |||||||||||||||||||||||||||||||
| Order Questions | ["3045300170", "3045300171", "3045300173"] | ||||||||||||||||||||||||||||||
| Order Questions Record Name | NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY | ||||||||||||||||||||||||||||||
| Inpatient Order Questions | [] | ||||||||||||||||||||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||||||||||||||||||||
| Order Specific Question Override | Yes | ||||||||||||||||||||||||||||||
| Inpatient Question Override | |||||||||||||||||||||||||||||||
| Location Restrict List Ip | |||||||||||||||||||||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||||||||||||||||||||
| Location Restrict List Include Ip | |||||||||||||||||||||||||||||||
| Location Restrict List Op | |||||||||||||||||||||||||||||||
| Location Restrict List Op Record Name | |||||||||||||||||||||||||||||||
| Location Restrict List Includes Op | |||||||||||||||||||||||||||||||
| Edp Amb Order Specific Questions Record Name | |||||||||||||||||||||||||||||||
| Edp Ip Order Specific Questions Record Name | |||||||||||||||||||||||||||||||
| Edp Ip Specimen Source | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||||||||||||||||||||
| Edp Op Specimen Source | |||||||||||||||||||||||||||||||
| Edp Ip Specimen Type | Blood | ||||||||||||||||||||||||||||||
| Edp Op Specimen Type | |||||||||||||||||||||||||||||||
| Derived Edp Ip Buttons S | Blood, Central Line Blood, Venous Blood, Capillary Blood, Arterial | ||||||||||||||||||||||||||||||
| Derived Edp Ip Buttons T | Blood | ||||||||||||||||||||||||||||||
| Derived Edp Op Buttons S | |||||||||||||||||||||||||||||||
| Derived Edp Op Buttons T | |||||||||||||||||||||||||||||||
| Ip Orderable | 1 | ||||||||||||||||||||||||||||||
| Op Orderable | 1 | ||||||||||||||||||||||||||||||
EPIC OP AOEs
| |||||||||||||||||||||||||||||||
| EPIC IP AOEs | |||||||||||||||||||||||||||||||
EPIC Components (results)
| |||||||||||||||||||||||||||||||